12 years of global business development support, to and from Japan
Biospire is a technology management consultancy company. We specialise in working with early-stage technology projects including those developed within academic environments. We provide support and development services to a variety of clients including university technology transfer offices, research councils, large corporates and technology-based SMEs. We also partner with other specialist consultancy companies.
Japan to Global
Why don't you explore your investment and business acquisition targets to high-end Japanese startup companies?
Biospire selects and supports best-in-class Japanese startup companies looking for global communications, collaborations, business development and investments.
Biospire introduces suitable startups to international stakeholders through an integrated endorsement system.
Global to Japan
Japan is a great place to explore your businesses. Our business development experts are fully versed in Japanese business culture to bridge you and the best business partners.
Biospire links to local ecosystems, government, distributors, business development specialists including sole-reps, and of course high value end-users.
Endorsement of selected Japanese startups
Japan is increasingly recognized a great place to invest, however we know that it is difficult to identify the most promising and valuable startups. Biospire’s experienced consultant team endorses hand-selected startup companies using our vast experience and databases.
Proactive global business development support
Proactive & strategic business entry support
We understand Japan’s unique business culture. This extends beyond language and supply-chain complications. Business is built on key decision-making through relationship development and trust based on culture. Biospire will be your business advisor to guide you to build the best strategies to enter the Japanese market.
Primary contact for your business transaction in Japan
Japanese startups may be missing a large international market. Many early-stage startups have not established clear global strategies. Biospire's global business experts will guide you to deliver global marketing, partnering you with the best investors and the supply chain management.
Contracts with distributors, end-users and legal entities are complicated in Japan. Biospire is a Japanese legal entity that works as your account to facilitate your business.
Japan to Global
Please contact directly for details
High-druggable small molecule building block and library provider
Highly purified, diverse and pharmaceutical compounds for clinical development. Currently seeking global business partners.
Innovative growth factor and cytokine development using peptide synthesis
Synthetic small molecule growth factors and cytokines using patented cyclic peptide production technologies. We are looking for global business partners.
Selected Japanese startup companies looking for global business development, collaboration and investment.
(Details of the contents are only shown in English.)
Global to Japan
License-free big surgical data from Japanese hospitals
Surg storage is a spin-out of the National Cancer Hospital in Japan and can now provide surgical videos and surgical-related data for commercial use and quality improvement of medical devices.
Drug discovery chemicals including Ionic liquid and Deep Eutectic Solvent (DES) supplier
Genotek provides unique chemical for solution to drug discovery market. High quality products with competitive pricing are accepted by major market including US and Europe.
Best-in-class technologies from the global market wishing to develop their businesses in Japan.
(details of the contents are only shown in Japanese)
Chemical designing professionals to support lead optimisation to process management (Cardiff, UK).
Customer-oriented CRO with speedy and friendly services (cover UK and Europe).
iPS-derived hepatocyte provider having disease modelling technology using CRISPR/CAS (Cambridge, UK).
Best-in-class microbial physiological and organs-on-chip company having multi-organ platform (Cambridge, UK).
Mycoplasma professional startup being able to synthesise antigen for diagnostic and vaccine platform (Tokyo, Japan).